Enteral Syringes Market By Product Type (Single Use Enteral Syringes, Home Use Enteral Syringes, Catheter Syringes), By Application (Oncology, Malnutrition, Neurological Disease, GI Related Disease, Other), By Age Group (Neonates And Pediatric, Adults) - Growth, Future Prospects, And Competitive Landscape, 2019 - 2027

Enteral syringe market to exhibit dynamic growth during the forecast period

The global enteral syringe market is increasing proficiently, expected to grow at a CAGR of 5.3%. Globally, the rising commonness of chronic illness and numerous lifestyle disorders will drive the market's overall growth. Enteral syringes deliver nutritional therapy or medications to different age groups, including pediatrics and adult patients. Enteral syringes are available in sizes ranging from 1ml to 60 ml and are generally used for patients in hospitals/clinics and home care. In addition, globally increasing neonatal admissions, gastrointestinal diseases, cancer, malnutrition, and overall management of treatment for various diseases are major factors driving the overall growth of the enteral syringes market.

Market Synopsis

Single-use enteral syringes expected to register higher growth by the end of 2027

New ENFit ISO standard single-use enteral syringes are gaining traction, developed to safely deliver enteral feeds, liquid medications, or nutrition to neonatal and adult patients. Enteral syringes (single-use/reusable) now come with ENFit compatibility with a standard purple color, differentiating from other IV feeding systems. Low-dose syringes also come with a female ENFit connection. In addition, top manufacturers now comply with ENFit standard design (new ISO80369 standard) and are receiving FDA clearance. The safety systems are also friendly with all other enteral feeding devices used within the clinics/hospital and home care settings for a smooth transition.

Oncology segment to witness a significant CAGR

The increasing prevalence of cancer and chronic diseases and a growing number of hospital admissions for various lifestyle diseases in the neonatal and adult populations will enhance the market's growth. In 2018, as per the statistics by International Agency for Research on Cancer (WHO), more than 18 million new cases were registered globally for cancer. Moreover, increasing admissions in the NICU segment on a global scale will drive growth globally. In addition, enhanced applications for enteral delivery, medicines, and nutritional content in the neonatal and pediatric segment will further spur revenue growth during the forecast period.

Increased research and development with strong product pipelines in the developed regions

Major players in the enteral syringe market are Cardinal Health Inc., Merit Medical Systems Inc., B. Braun Melsungen AG, Baxter International, Inc., Terumo Corporation, Vygon S.A., Koninklijke Philips N.V., Retractable Technologies Inc., Medline Industries Inc., Gerresheimer AG, Abbott Laboratories Inc., Kentec Medical, Inc., Mikell Ltd., Thermo Fischer, Inc., and others. Novel product launches with higher patient safety and compatibility (for all age groups), partnerships, new technology expansion in developing nations, and improved R&D on enteral syringes will further drive the overall market growth. For e.g. In Aug 2016, NeoMed. In addition, Inc. and Medtronic plc received the U.S FDA 510(k) clearance for low-dose tip ENFit syringes. FDA 510(k) clearance permits both techniques, enteral and direct oral administration.

Historical & Forecast Period

This study report represents an analysis of each segment from 2017 to 2027, considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.

Segmentation Product Type (2017–2027; US$ Mn)

  • Single Use Enteral Syringes
  • Home Use Enteral Syringes
  • Catheter Syringes

 Application (2017–2027; US$ Mn)

  • Oncology
  • Malnutrition
  • Neurological Disease
  • GI-related Disease
  • Other (Diabetes, Hyper Metabolism)

 Age Group Segment (2017–2027; US$ Mn)

  • Neonates and Pediatric
  • Adults

 Geography Segment (2017–2027; US$ Mn)

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe
  • Asia Pacific (Japan, China, India, Rest of Asia Pacific)
  • Rest of the World (the Middle East & Africa, Latin America)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better market understanding of the overall enteral syringe market. The global report also represents the competitive landscape based on market initiatives and strategies, product portfolio, and business strengths.

Frequently asked questions :

The market for Enteral Syringes Market is expected to reach US$ XX Bn in 2027.

The Enteral Syringes Market is expected to see significant CAGR growth over the coming years, at XX%.

he report is forecasted from 2019-2027.

The base year of this report is 2018.

Cardinal Health Inc., Merit Medical Systems Inc., B. Braun Melsungen AG, Baxter International, Inc., Terumo Corporation, Vygon S.A. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Sep 2019
Category:  Medical Devices
Report ID:   59931
Report Format:   PDF
Pages:   120
Rating:    4.2 (56)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support